151 related articles for article (PubMed ID: 23055731)
61. Targeted delivery of siRNA-generating DNA nanocassettes using multifunctional nanoparticles.
Cho YS; Lee GY; Sajja HK; Qian W; Cao Z; He W; Karna P; Chen X; Mao H; Wang YA; Yang L
Small; 2013 Jun; 9(11):1964-73. PubMed ID: 23292656
[TBL] [Abstract][Full Text] [Related]
62. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
63. Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery.
Alameh M; Dejesus D; Jean M; Darras V; Thibault M; Lavertu M; Buschmann MD; Merzouki A
Int J Nanomedicine; 2012; 7():1399-414. PubMed ID: 22457597
[TBL] [Abstract][Full Text] [Related]
64. Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles.
Kaushal N; Tiruchinapally G; Durmaz YY; Bao L; Gilani R; Merajver SD; ElSayed MEH
J Control Release; 2018 Nov; 289():79-93. PubMed ID: 30149048
[TBL] [Abstract][Full Text] [Related]
65. Overexpression of CFL1 in gastric cancer and the effects of its silencing by siRNA with a nanoparticle delivery system in the gastric cancer cell line.
Daryabari SS; Fathi M; Mahdavi M; Moaddab Y; Hosseinpour Feizi MA; Shokoohi B; Safaralizadeh R
J Cell Physiol; 2020 Oct; 235(10):6660-6672. PubMed ID: 31990066
[TBL] [Abstract][Full Text] [Related]
66. Polymer Based Gene Silencing: In Vitro Delivery of SiRNA.
Carlos MI; Schätzlein A; Uchegbu I
Methods Mol Biol; 2016; 1445():149-57. PubMed ID: 27436317
[TBL] [Abstract][Full Text] [Related]
67. An albumin-mediated cholesterol design-based strategy for tuning siRNA pharmacokinetics and gene silencing.
Bienk K; Hvam ML; Pakula MM; Dagnæs-Hansen F; Wengel J; Malle BM; Kragh-Hansen U; Cameron J; Bukrinski JT; Howard KA
J Control Release; 2016 Jun; 232():143-51. PubMed ID: 27084489
[TBL] [Abstract][Full Text] [Related]
68. Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging.
Yezhelyev MV; Qi L; O'Regan RM; Nie S; Gao X
J Am Chem Soc; 2008 Jul; 130(28):9006-12. PubMed ID: 18570415
[TBL] [Abstract][Full Text] [Related]
69. Para amino benzoic acid-derived self-assembled biocompatible nanoparticles for efficient delivery of siRNA.
Reddy TL; Krishnarao PS; Rao GK; Bhimireddy E; Venkateswarlu P; Mohapatra DK; Yadav JS; Bhadra U; Bhadra MP
Int J Nanomedicine; 2015; 10():6411-23. PubMed ID: 26491299
[TBL] [Abstract][Full Text] [Related]
70. Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles.
Mehta A; Dalle Vedove E; Isert L; Merkel OM
Pharm Res; 2019 Jul; 36(9):133. PubMed ID: 31289919
[TBL] [Abstract][Full Text] [Related]
71. Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.
Biswas S; Deshpande PP; Navarro G; Dodwadkar NS; Torchilin VP
Biomaterials; 2013 Jan; 34(4):1289-301. PubMed ID: 23137395
[TBL] [Abstract][Full Text] [Related]
72. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
[TBL] [Abstract][Full Text] [Related]
73. Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.
Ragelle H; Colombo S; Pourcelle V; Vanvarenberg K; Vandermeulen G; Bouzin C; Marchand-Brynaert J; Feron O; Foged C; Préat V
J Control Release; 2015 Aug; 211():1-9. PubMed ID: 25989603
[TBL] [Abstract][Full Text] [Related]
74. A Gold Nanoparticle Platform for the Delivery of Functional TGF-β1 siRNA Into Cancer Cells.
Wu J; Liu B; Wu H; Wu Y; Zhang W; Zhao S; Zhang L; Pan X; Gao W; Wang X; Yuan Y; Zhang Y
J Biomed Nanotechnol; 2016 Apr; 12(4):800-10. PubMed ID: 27301206
[TBL] [Abstract][Full Text] [Related]
75. Fabrication of electrospun zein nanofibers for the sustained delivery of siRNA.
Karthikeyan K; Krishnaswamy VR; Lakra R; Kiran MS; Korrapati PS
J Mater Sci Mater Med; 2015 Feb; 26(2):101. PubMed ID: 25655500
[TBL] [Abstract][Full Text] [Related]
76. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery.
Taratula O; Garbuzenko OB; Kirkpatrick P; Pandya I; Savla R; Pozharov VP; He H; Minko T
J Control Release; 2009 Dec; 140(3):284-93. PubMed ID: 19567257
[TBL] [Abstract][Full Text] [Related]
77. Effect of surface properties on liposomal siRNA delivery.
Xia Y; Tian J; Chen X
Biomaterials; 2016 Feb; 79():56-68. PubMed ID: 26695117
[TBL] [Abstract][Full Text] [Related]
78. Identification and characterization of receptor-specific peptides for siRNA delivery.
Ren Y; Hauert S; Lo JH; Bhatia SN
ACS Nano; 2012 Oct; 6(10):8620-31. PubMed ID: 22909216
[TBL] [Abstract][Full Text] [Related]
79. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
[TBL] [Abstract][Full Text] [Related]
80. Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing.
Amar-Lewis E; Azagury A; Chintakunta R; Goldbart R; Traitel T; Prestwood J; Landesman-Milo D; Peer D; Kost J
J Control Release; 2014 Jul; 185():109-20. PubMed ID: 24794893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
